BioSpace News Archive

Antibe Therapeutics Inc. has filed its financial and operating results for the fiscal quarter ended December 31, 2021.

Oncology Pharma, Inc. announced that they intend to work jointly to fast track the development of therapeutic uses related to treatment in humans with pancreatic cancer of Regen’s patented ANTIGEN SPECIFIC MRNA CELLULAR CANCER VACCINES.

Cidara Therapeutics, Inc. (Nasdaq: CDTX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational New Drug (IND) application for its lead flu drug-Fc conjugate (DFC), CD388 – a highly potent, long-acting antiviral immunotherapy designed to deliver universal prevention and treatment of seasonal and pandemic influenza.

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer will participate in a Fireside Chat at the SVB Leerink 11th Annual Global Healthcare Conference.

The bacterial & viral specimen collection market has been projected to experience various growth opportunities in the forthcoming years.

Global health services company Cigna Corporation (NYSE:CI) announced today that Eric Palmer, president and chief executive officer of Evernorth, will present at the Cowen 42nd Annual Health Care Conference on March 7, 2022 through a virtual webcast.

The radiation dose management solution market has been projected to experience various growth avenues in the foreseeable years.

Echelon, the connected fitness company revolutionizing the way people move, is announcing a multi-year collaboration with the American Heart Association to help educate its community on the importance of exercise and heart health.